MannKind Corp. buy BiotechBee
Start price
08.09.24
/
60%
€5.49
Target price
28.02.27
€7.00
Performance (%)
17.70%
End price
14.12.24
€6.46
Summary
This prediction ended on 14.12.24 with a price of €6.46. The prediction had a final performance of 17.70%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MannKind Corp. | 4.502% | 4.502% | -18.988% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of MannKind Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year